NSE ScannerOpen the scanner

Hospitals & Diagnostics · Medical/Nursing Services · NSE: NIDAN · data 2026-10-30

Nidan Laboratories and Healthcare Limited

₹130.00% on 29 OctHealth: Weak 3.9/10
Dec 2025Low ₹12.3 · High ₹19-31.6%

In plain words

Price: 47.8% below its 52-week high of ₹24.9.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price
₹13
Market cap
₹18 cr
P/E
12
P/B
—
ROE
2.2%
ROCE
4.0%
Debt / equity
0.16
Dividend yield
0.00%
1-year return
-33.3%
52-week high
₹24.9
52-week low
₹11.5
Operating margin
11.5%

Growth

Revenue (last 12 months)₹26 cr
Net profit (last 12 months)₹2 cr
Sales growth, 3 years (yearly)1.7%
Profit growth, 3 years (yearly)-24.8%

Smart-money activity

5/100 · Weak over the last ~60 sessions

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Common questions

Is Nidan Laboratories and Healthcare Limited debt-free?

Its latest reported debt-to-equity ratio is 0.16.

What is Nidan Laboratories and Healthcare Limited's P/E ratio?

About 12, based on the last 12 months' earnings and a price of ₹13 (data 2026-10-30).

What is the 52-week high and low of Nidan Laboratories and Healthcare Limited?

The 52-week high is ₹24.9 and the 52-week low is ₹11.5.

Similar companies

CHANDAN HEALTHCARE LIMITED (CHANDAN) · Rays of Belief Limited (MOMSBELIEF) · Pramodini Medicare Limited (PRAMODINI) · Lotus Eye Hospital And Institute Ltd (LOTUSEYE) · Vaidya Sane Ayurved Laboratories Limited (MADHAVBAUG)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open NIDAN in NSE Scanner →
Share on WhatsAppShare on Telegram